Adherence to Preventive Care for Cervical Cancer
Adh-NYC-EP
Adherence to Screening and Follow-up Diagnostic and Treatment Services for Cervical Cancer Prevention
1 other identifier
observational
400
1 country
3
Brief Summary
In the United States, the highest incidence of cervical cancer occurs in inner city urban centers, rural areas, the deep South, Appalachia and the U.S.-Mexico border. The goal of this study is to study predictors of adherence among patients seeking care at an inner city medical center in New York City and the U.S. Mexico border for cervical cancer prevention, namely, Pap smears and colposcopy exams.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2015
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2015
CompletedStudy Start
First participant enrolled
April 1, 2015
CompletedFirst Posted
Study publicly available on registry
April 2, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedApril 10, 2015
April 1, 2015
1.7 years
March 16, 2015
April 9, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Adherence to screening, colposcopy and follow-up treatment
A survey will be administered to patients who present for a routine Pap smear exam, a follow-up colposcopy exam. Medical records will be reviewed to document adherence to treatments post-colposcopy
1-2 hour interview during clinic visit and review of patients' medical records during surveillance period (up to 2 years)
Eligibility Criteria
Eligible patients who present to the gynecology clinic for a Pap smear exam or a colposcopy exam following an abnormal Pap smear.
You may qualify if:
- women who are at least 21 years old
- are seeking care for a Pap smear exam
- are seeking care for a colposcopy exam for the first time
- are not pregnant by self-report
- are able to provide informed consent
You may not qualify if:
- women who do not meet the above eligibility criteria
- women who have no prior history of a hysterectomy
- women who have previously participated in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Brookdale University Hospital and Medical Center
Brooklyn, New York, 11212, United States
University of Texas at El Paso
El Paso, Texas, 79902, United States
Texas Tech University Health Science Center
El Paso, Texas, 79905, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michele Follen, MD, PhD
Brookdale University Hospital and Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair of Department of Obstetrics and Gynecology
Study Record Dates
First Submitted
March 16, 2015
First Posted
April 2, 2015
Study Start
April 1, 2015
Primary Completion
December 1, 2016
Study Completion
December 1, 2017
Last Updated
April 10, 2015
Record last verified: 2015-04